Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Boehringer Ingelheim
Baxter
McKesson
AstraZeneca
Farmers Insurance
Moodys
US Department of Justice

Generated: January 22, 2019

DrugPatentWatch Database Preview

CIMETIDINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine hydrochloride and what is the scope of cimetidine hydrochloride freedom to operate?

Cimetidine hydrochloride is the generic ingredient in four branded drugs marketed by Dava Pharms Inc, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Glaxosmithkline, Ani Pharms Inc, Apotex Inc, Cycle Pharms Ltd, G And W Labs Inc, Hi Tech Pharma, Lannett Co Inc, Pharm Assoc, and Wockhardt Bio Ag, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine hydrochloride. One supplier is listed for this compound.

Pharmacology for CIMETIDINE HYDROCHLORIDE
Synonyms for CIMETIDINE HYDROCHLORIDE
059C302
1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine hydrochloride
2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine monohydrochloride
70059-30-2
71989-90-7
AC-4278
AC1L1A6G
AKOS015961108
AN-12137
AS-15040
C10H16N6S.HCl
CHEBI:50362
CHEMBL1201051
Cimetex
Cimetidine Hcl
CIMETIDINE HCL IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Cimetidine hydrochloride (TN)
Cimetidine hydrochloride (USP)
Cimetidine hydrochloride [USAN:USP]
Cimetidine hydrochloride [USAN]
Cimetidine hydrochloride in sodium chloride 0.9% in plastic container
Cimetidine hydrochloride, European Pharmacopoeia (EP) Reference Standard, European Pharmacopoeia (EP) Reference Standard
Cimetidine hydrochloride, pharmaceutical secondary standard; traceable to USP and PhEur
Cimetidine hydrochloride, United States Pharmacopeia (USP) Reference Standard
D03503
EINECS 274-297-2
EINECS 276-264-8
Endo
FT-0602954
Guanidine, N-cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-,monohydrochloride
Guanidine, N'-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-, monohydrochloride
Guanidine, N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-, monohydrochloride
HE058480
LS-73442
MolPort-023-220-419
N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine hydrochloride
N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine monohydrochloride
N-CYANO-N'-METHYL-N''-[2-[[(5-METHYL-1H-IMIDAZOL-4-YL)METHYL]THIO]ETHYL]GUANIDINE MONOHYDROCHLORIDE
N737
SCHEMBL11156749
SCHEMBL42142
SCHEMBL42144
TAGAMET HCL IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Tagamet hydrochloride in sodium chloride 0.9% in plastic container
Tagamet Injection
Tagamet Liquid
TL8004938
UNII-WF10491673
W-104570
WF10491673

US Patents and Regulatory Information for CIMETIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074664-001 Oct 28, 1997 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074859-001 Jul 9, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074468-001 Dec 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074269-001 Dec 27, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074412-001 Mar 28, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074344-001 Jan 31, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for CIMETIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline TAGAMET cimetidine hydrochloride INJECTABLE;INJECTION 017939-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET cimetidine hydrochloride SOLUTION;ORAL 017924-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET cimetidine hydrochloride SOLUTION;ORAL 017924-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET cimetidine hydrochloride INJECTABLE;INJECTION 017939-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Sign Up ➤ Sign Up
Glaxosmithkline TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 019434-001 Oct 31, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Deloitte
Queensland Health
Fish and Richardson
Colorcon
QuintilesIMS
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.